Physician profile
David Michael Auerbach
NPI 1851320352
$36,534.86
in general payments reported to CMS, 2019-2025
13 companies · $3,199 in 2025
The $3,199 reported for 2025 was more than what 88% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,940 · 2020: $4,107 · 2021: $13K · 2022: $2,631 · 2023: $4,066 · 2024: $3,987 · 2025: $3,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $9,829 · Food and Beverage: $723 · Travel and Lodging: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $9,829.01 |
| Food and Beverage | $722.95 |
| Travel and Lodging | $700.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $22,066.50 | 2019-2025 | Variax |
| Maruho Medical, INC. | $12,213.70 | 2019-2022 | |
| US Implant Solutions, LLC | $497.59 | 2019 | |
| Arthrex, INC. | $451.35 | 2024 | |
| Smith+Nephew, INC. | $415.72 | 2021-2025 | Bone Anchors With Arthroscopic Delivery System, Double Pump Rf, Twinfix / Durabraid |
| Saxum Surgical, INC. | $394.66 | 2024 | |
| Micromed INC | $135.88 | 2021 | |
| Spr Therapeutics, INC | $102.51 | 2024 | Sprint Pns System |
| Depuy Synthes Sales INC. | $82.00 | 2021 | |
| Trevena, INC. | $69.20 | 2021 | |
| Linvatec Corporation | $55.48 | 2021-2022 | |
| Medartis INC. | $50.27 | 2025 | Aptus |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$35,805.34 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Auerbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.